Fox Run Management, L.L.C. Heron Therapeutics, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$22.03 - $32.01 $173,332 - $251,854	-7,868 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$30.0 - $40.85 $236,040 - $321,407	7,868 New	7,868 $249,000
Q1 2018 Apr 17, 2018	SELL	$18.43 - $28.8 $406,381 - $635,040	-22,050 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$14.8 - $18.85 $70,300 - $89,537	4,750 Added 27.46%	22,050 $399,000
Q3 2017 Oct 23, 2017	BUY	$14.65 - $16.85 $253,445 - $291,505	17,300	17,300 $279,000

175

118M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $192M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.